Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00567567 · OUTCOME

Incidence Rate of Local Recurrence

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage 3-year cumulative incidence
Interval / dispersion
95% Confidence Interval
Time frame
Up to 3 years

What was measured

Cumulative incidence rate of local recurrence comparison between ANBL0532 patients randomized or assigned to receive single CEM transplant and boost radiation versus the historical A3973 patients who were transplanted and received boost radiation.

Analysis population: Eligible patients randomized or assigned to the single HST (CEM) treatment arm who also received boost radiation.

Groups in this outcome

Single HST (CEM)

Induction therapy + single myeloablative consolidation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Single HST (CEM)77

Reported measurements

Source class 1
Values in Percentage 3-year cumulative incidence · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Single HST (CEM)15.7Not reported7.523.9Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    The cumulative incidence rates of local recurrence between patients from ANBL0532 randomized or assigned to receive single CEM transplant and boost radiation and A3973 patients who were transplanted and received boost radiation were compared using Gray's test.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER_LEGACY
    p Value
    0.5615
    param Type
    Gray's test statistic
    param Value
    0.33709
    statistical Method
    Gray's test for competing risks
Complete source fields
analyses
  1. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    The cumulative incidence rates of local recurrence between patients from ANBL0532 randomized or assigned to receive single CEM transplant and boost radiation and A3973 patients who were transplanted and received boost radiation were compared using Gray's test.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER_LEGACY
    p Value
    0.5615
    param Type
    Gray's test statistic
    param Value
    0.33709
    statistical Method
    Gray's test for competing risks
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7.5
        upper Limit
        23.9
        value
        15.7
denoms
  1. counts
    1. group Id
      OG000
      value
      77
    units
    Participants
description
Cumulative incidence rate of local recurrence comparison between ANBL0532 patients randomized or assigned to receive single CEM transplant and boost radiation versus the historical A3973 patients who were transplanted and received boost radiation.
dispersion Type
95% Confidence Interval
groups
  1. description
    Induction therapy + single myeloablative consolidation
    id
    OG000
    title
    Single HST (CEM)
param Type
NUMBER
population Description
Eligible patients randomized or assigned to the single HST (CEM) treatment arm who also received boost radiation.
reporting Status
POSTED
time Frame
Up to 3 years
title
Incidence Rate of Local Recurrence
type
PRIMARY
unit Of Measure
Percentage 3-year cumulative incidence

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice